Company invites individual and institutional investors as well as advisors to attend interactive real-time virtual VirtualInvestorConferences.com
BOSTON, May 8, 2017 /CNW/ -- Implanet (OTCQX: PYDGF), based in Boston, a medical technology company focused on spine, knee and arthroscopy products, today announced that Ludovic Lastennet, Chief Executive Officer, will present live at VirtualInvestorConferences.com on May 11, 2017.
DATE: Thursday, May 11, 2017
TIME: 12:00 PM ET
This will be a live, interactive online event where investors are invited to ask the company questions in real-time - both in the presentation hall as well as the association's "virtual trade booth." If attendees are not able to join the event live on the day of the conference, an on-demand archive will be available for 90 days.
It is recommended that investors pre-register and run the online system check to save time and receive event updates.
Learn more about the event at www.VirtualInvestorConferences.com.
Recent Company Highlights
- 2016 group sales were up 18% to €7.8 million
- 2016 spine sales (JAZZ) were up 46% to €4.1 million
- Q1 2017 sales up +3% to €2.05 million while JAZZ sales were up 27% to €1.1 million
- On April 3, 2017 Implanet announced its intention to transfer shares from the Euronext market to the Alternext Paris multilateral trading facility
Based near Bordeaux (FR), IMPLANET is a company having 48 employees in France and in the US, having its US subsidiary in Boston. It had been funded by European institutional and private investors. Implanet focuses on spine, knee and arthroscopy products.
Its flagship product, JAZZ™ obtained the 510(k) clearance from the Food and Drug Administration (FDA) in the United States and the CE mark in Europe. The JAZZ™ Band latest generation implant, is intended to improve the treatment of spinal disorders requiring spinal fusion surgery. Protected by 4 sets of global patents.
Taking into account the evolutions in the healthcare system all over the world, the IMPLANET Marketing team identifies a portfolio of products and services based on a detailed analysis of socio-economic, regulatory, demographic and cultural specifications. IMPLANET R&D team focuses on a scientifically and clinically proven implant design, using top quality materials tested to the highest prevailing standards, associated with simple and user-friendly instrumentations.
Our various workgroups, composed of surgeons, experienced engineers and product managers work closely together to offer a range of implants with scientifically sound specifications and highest quality to adequately respond to requirements of healthcare professionals.
Based on these market elements and facts, IMPLANET is able to provide the best of what science and experience have to offer, while ensuring to the stakeholders the best value for their products, their needs and demands.
Since 2010, VirtualInvestorConferences.com, created by BetterInvesting (NAIC) and PRNewswire, has been the only monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with investors using a graphically-enhanced online platform.
Designed to replicate the look and feel of location-based investor conferences, Virtual Investor Conferences unites PR Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's extensive retail investor audience network.
For further information: Implanet, Ludovic Lastennet, Chief Executive Officer, (917) 385-2160, [email protected]; VirtualInvestorConferences.com: Bradley H. Smith, Director of Marketing, IR and Compliance Services, PR Newswire, +1.201.947.7157, [email protected]